CLB Core Laboratories
Core Laboratories earnings company data as of 3:00 PM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 28 Oct | EPS | 0.17 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by CLB's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $54K bought by 1 insider
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Lawrence Bruno CEOBuy$54K 5,000 shares at $10.78 +1.9% to stakeTraded Jul 31 Filed Aug 4
Also filed in the last 12 months, not counted as buying or selling: 17 option exercises and 11 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 20 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K/A | 2.02 | Filing Doc | |
| 8-K | 5.03,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.